Over one thousand people in Northern Ireland have been involved in the study carried out by Dr Tony O’Neill from the School of Medicine and Dentistry and two professors from Virginia Commonwealth University.
It typically starts in late adolescence, and can have a devastating effect on sufferers and carers.
The discovery of the gene, MEGF10, which is associated with severe schizophrenia, could be a step in the right direction towards helping those affected.
The study found abnormally high levels of the gene in a region of the brain previously shown to be linked to the condition by Dr O’Neill and his colleagues.
Dr O’Neill, from the Department of Psychiatry at Queen’s, said: “This further finding helps piece together the complex picture underlying risk to schizophrenia and offers the hope of more successful interventions in the future.
“We are beginning to understand how difficulties with the developing brain can compromise important brain systems leading to the bewildering and distressful symptoms of schizophrenia. It is a really exciting time for psychiatric research.”
The study is the latest in a series of publications resulting from a 20 year collaboration between Queen’s and Virginia Commonwealth University.
The group was the first to identify Dysbindin, the first risk gene for schizophrenia. That finding was described as the most important in psychiatry for 20 years and was replicated in many other populations.
Lisa Mitchell | alfa
Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel
Smelling the forest – not the trees
12.12.2018 | Universität Konstanz
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
12.12.2018 | Life Sciences
12.12.2018 | Life Sciences
12.12.2018 | Health and Medicine